MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.
By Bozena Kaminska. Biochimica et Biophysica Acta, 2005
1,257 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/7e97320978a7aabee2c279ca94c0cd9808b282ae
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Iddir
- Alex Brito
- G. Dingeo
- Sofia Sosa Fernandez Del Campo
- H. Samouda
- Michael R. La Frano
- Yinglun Li
- J. Fang
Citations in the corpus
- The Immunomodulatory and Anti-Inflammatory Role of Polyphenols (2018, background): “Preclinical data propose an anti-inflammatory role of JNK and p38 cascades inhibitors [98,99].”
- TNF and MAP kinase signaling pathways (2014, neutral): “promoter induction may require interaction between several of these transcription factors, including NF-κB, EGR-1 and cJun/AP-1 [72, 73].”
- Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis (2020, background): “These mediate inflammation through the activation of receptors, for instance toll-like receptors (TLRs), IL-1, IL-6 receptors, and the TNF-receptor [46].”
- Inflammatory responses and inflammation-associated diseases in organs (2015, background): “Primary inflammatory stimuli, including microbial products and cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), mediate inflammation through interaction with the TLRs, IL-1 receptor (IL-1R), IL-6 receptor (IL-6R), and the TNF receptor (TNFR) [20].”